• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.49 Up 0.02(4.26%) Jul 2, 4:01PM EDT
    Add to Portfolio
    Prev Close:0.47
    Open:0.48
    Bid:0.48 x 10300
    Ask:0.49 x 400
    1y Target Est:3.00
    Beta:1.63
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:0.47 - 0.50
    52wk Range:0.43 - 1.13
    Volume:145,255
    Avg Vol (3m):614,056
    Market Cap:44.22M
    P/E (ttm):N/A
    EPS (ttm):-0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCUp 4.26%44.22M
    AGENDown 1.94%724.60M
    DNDN 0.00%0.00
    STMLDown 1.52%208.44M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.18
    Quarterly EPS Est (Jun-15) :-0.05
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback